Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Paolella B"'
Autor:
Neggers, J. 1, Paolella, B. 2, Asfaw, A. 2, Rothberg, M. 2, Skipper, T. 2, Kalekar, R. 1, Burger, M. 2, Kugener, G. 2, Jérémie, K. 2, Yang, A. 1, Nancy, D. 2, Abdusamad, M. 2, Cherniack, A. 2, Tscherniak, A. 2, Hong, A. 3, Hahn, W. 2, Stegmaier, K. 3, Golub, T. 2, Vazquez, F. 2, Aguirre, A. 1
Publikováno v:
In European Journal of Cancer October 2020 138 Supplement 2:S8-S8
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Pandey A; University of California, San Francisco, San Francisco, United States., Rohweder PJ; University of California, San Francisco, United States., Chan LM; University of California, San Francisco, San Francisco, CA, United States., Ongpipattanakul C; University of California, San Francisco, United States., Chung DH; University of California, San Francisco, San Francisco, United States., Paolella B; University of California, San Francisco, San Francisco, United States., Quimby FM; University of California, San Francisco, San Francisco, CA, United States., Nguyen N; University of California, San Francisco, United States., Verba KA; University of California, San Francisco, San Francisco, United States., Evans MJ; University of California, San Francisco, San Francisco, CA, United States., Craik CS; University of California, San Francisco, San Francisco, CA, United States.
Publikováno v:
Cancer research [Cancer Res] 2024 Dec 10. Date of Electronic Publication: 2024 Dec 10.
Autor:
Krakow J; Maverick Therapeutics, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Brisbane, CA, USA., Hammel M; Molecular Biophysics and Integrated Bioimaging, Lawrence Berkeley National Laboratory, Berkeley, CA, USA., Zhu Y; Maverick Therapeutics, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Brisbane, CA, USA., Hillier BJ; Maverick Therapeutics, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Brisbane, CA, USA., Paolella B; Maverick Therapeutics, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Brisbane, CA, USA., Desmarais A; Maverick Therapeutics, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Brisbane, CA, USA., Wall R; Maverick Therapeutics, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Brisbane, CA, USA., Chen TT; Maverick Therapeutics, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Brisbane, CA, USA., Pei R; Maverick Therapeutics, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Brisbane, CA, USA., Karunatilake C; Maverick Therapeutics, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Brisbane, CA, USA., DuBridge R; Maverick Therapeutics, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Brisbane, CA, USA., Vinogradova M; Maverick Therapeutics, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Brisbane, CA, USA.
Publikováno v:
Antibody therapeutics [Antib Ther] 2021 Dec 16; Vol. 5 (1), pp. 1-10. Date of Electronic Publication: 2021 Dec 16 (Print Publication: 2022).